Pharmacological blockade of CB1Rs significantly reduces hyperglycemia, improves glucose tolerance and/or insulin sensitivity in obese diabetic Zucker rats or diet-induced obese mice and humans73–75. The gene discussed is INS; the disease is Hyperglycemia.